About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 398 record(s)
Req # A-2021-10669
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Purdue Pharma (Canada) over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2021-10670
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Eczema Society of Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2021-10671
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and PHA Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2014-000213
“2013-14 records identifying legal drugs that led to 10 or more deaths in Canada & 100 or more serious ADR’s in Canada. 2013-14 drug safety review reports that are unavailable online. List of all drug safety reviews done to date. 2013-14 list of drugs removed and recalled from the CDN market.”Organization: Health Canada
September 2020
Req # A-2015-000361
All Health Canada reviewer reports and notes related to the New Drug Submission for Saxenda® (liraglutide) (DIN 02437899).Organization: Health Canada
September 2020
Req # A-2016-000929
Copy of the current Risk Management Plan for Humira.Organization: Health Canada
September 2020
Req # A-2020-000794
Requesting the rates of male babies and female babies born as a result of fertility treatments, by fertility treatment, for each fertility clinic in Ontario over the last 10 years.Organization: Health Canada
September 2020
Req # A-2017-001207
Records between Rosa Foods Inc. and Health Canada in relation to the product's classification, marketing and the decision to ban the sale of Soylent products within Canada. Records within Health Canada relating to Rosa Labs, Inc. and the recent decision to ban the Soylent product. Aug 2017 - Nov 2017.Organization: Health Canada
September 2020
Req # A-2019-000403
Letters from Health Canada to all applicant companies regarding any abbreviated new drug submissions (ANDSs) made since October 1, 2019 for Azacitadine.Organization: Health Canada
September 2020
Req # A-2019-000762
All material pertaining to authorizing/approving, the re-organization of the Policy and Regulatory Strategies Directorate of the Regulatory Operations and Enforcement Branch that took place beginning in approximately March 2019 up to 19 August 2019.Organization: Health Canada
September 2020